Study in a Sentence: A new multi-component, transformer-based, open-source AI model, Boltz-2, predicts protein–drug binding ...

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the ...

Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts. On July 29, the ...

Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

Researchers from the Cancer Genetics and Epigenetics group at IGTP have published a study in Scientific Reports presenting a ...

The Commonwealth Bank of Australia made headlines when it announced last week it would cut 45 call centre jobs, thanks to the ...

Co-authors: Roger Hancock, CEO of Recall InfoLink, and Gillian Kelleher, president and CEO of Kelleher Consultants LLC. -- OPINION -- On July 9, the FDA ...

This review explores how generative AI, through models like VAEs, GANs, transformers, and diffusion networks is ...

Genie 3 by Google DeepMind creates dynamic, 720p AI worlds in real time with promptable events and consistent physics over several minutes.

The global biosimulation market is set for explosive growth, with a new forecast predicting its valuation will increase from ...

This important study provides evidence for dynamic coupling between translation initiation and elongation that can help maintain low ribosome density and translational homeostasis. The authors combine ...